Content related to the tag: NIST CHO Cells


Description : NISTCHO cells are a newly released recombinant cell line that produce cNISTmAb, an industry relevant, open access monoclonal antibody to RSV. The NISTCHO cell line was developed by the National Institute of Standards and Technology (NIST) and MilliporeSigma and is available as a research grade test material (RGTM 10197). A lab-based curriculum has been developed to facilitate the use of the NIST CHO cell line in biomanufacturing courses and workforce development programs. Standard operating procedures, batch records and corresponding data will be shared for small scale NIST CHO growth and mAb production. Outcomes of undergraduate research projects on ... Read more


Mon, Aug 5 2024 to Thu, Aug 8 2024

The Fourth Virtual Hackathon for Developing CURES in Antibody Engineering will be held August 5-8th, 2024

Visit our website to learn about the projects and apply.

This work is funded by a grant from the National Science Foundation's Advanced Technological Education program ( DUE ... Read more

Filed Under: